Volume
Open
Day's Low
Day's High
52 Wk Low
52 Wk High
Bid
Ask
EPS
PE Ratio
Shares
Market Cap
Dividend
Ex-Div Date
Yield
Interested in Gold Updates?
Receive the latest updates on the gold and silver markets.
...
Health Technology » Biotechnology
| symbol | company | %chng | last | %short | avg$volume | |
|---|---|---|---|---|---|---|
| CELG | Celgene Corporation | 0.55% | 89.14 | 1.3% | $797.85m | |
| AMGN | Amgen Inc. | 1.08% | 187.50 | 1.2% | $644.97m | |
| GILD | Gilead Sciences, Inc. | 0.29% | 65.74 | 0.9% | $476.37m | |
| BIIB | Biogen Inc. | 1.30% | 325.33 | 1.3% | $432.61m | |
| ILMN | Illumina, Inc. | 1.41% | 301.06 | 3.5% | $311.78m | |
| REGN | Regeneron Pharmaceuticals, Inc. | 0.93% | 422.52 | 2.6% | $280.54m | |
| VRTX | Vertex Pharmaceuticals Incorporated | 1.48% | 185.76 | 1.9% | $246.69m | |
| ALXN | Alexion Pharmaceuticals, Inc. | 1.71% | 129.73 | 2.0% | $214.36m | |
| SRPT | Sarepta Therapeutics, Inc. | 2.52% | 139.98 | 15.4% | $157.00m | |
| A | Agilent Technologies, Inc. | 0.67% | 78.41 | 1.6% | $155.05m | |
| EXAS | Exact Sciences Corporation | 10.52% | 92.04 | 25.3% | $150.72m | |
| INCY | Incyte Corporation | 1.82% | 84.85 | 2.5% | $112.02m | |
| ARRY | Array BioPharma Inc. | 2.33% | 23.24 | 8.2% | $111.41m | |
| NBIX | Neurocrine Biosciences, Inc. | 2.07% | 78.91 | 5.1% | $80.47m | |
| EXEL | Exelixis, Inc. | 1.41% | 21.52 | 6.4% | $79.74m |
Company Profile
Alexion Pharmaceuticals, Inc. is a biopharmaceutical company, which focuses on serving patients with devastating and ultra-rare disorders through the development and commercialization of life-transforming therapeutic products. Its products include ultomiris, soliris, strensiq and kanuma. The company was founded by Joseph A. Madri, David W. Keiser, Stephen P. Squinto and Leonard Bell in January 1992 and is headquartered in Boston, MA.